Tus kws kho mob
upcoming-medical-and-behaviorial-health-policies-effective-august-31-2020.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2521 - 2530 ntawm 4139
Tus kws kho mob
QP52-20 Claim Submission Requirements for Lab Services
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 10, 2020
Tus kws kho mob
QP55-20 Housing Stabilization Services – New MHCP Benefit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Ntawv Thov Nyiaj Rov Qab thiab Kev Thov Kom Rov Txiav Txim Dua
Daim Foos Lus Tsis Txaus Siab Tsis Pub Muaj Kev Ntxub Ntxaug
Tus kws kho mob
QP31R1-20 Update: Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP54-20 MHCP Pharmacy Benefit Update — Pharmacy Benefit Exclusion for Nexplanon® and Trodelvy™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP57-20 Commercial Pharmacy Benefit Update: Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP53-20 Commercial Pharmacy Benefit Exclusion for Nexplanon®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP56-20 U.S. Department of Health and Human Services Announced Additional Opportunity for Funding
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP49-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema (HAE)
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 10, 2020